Orange Book product · Brand (NDA)

AZILECT

RASAGILINE MESYLATE

Brand (NDA)NDA 021641TE ABRX TEVA

May 16, 2006

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
May 16, 2006
20 yr 5 mo ago
Today
Patent 7572834 expires
Listed drug product patent expiration.
Dec 05, 2026
in 6 mo
Patent 7815942 expires
Listed drug substance patent expiration.
Aug 27, 2027
in 1 yr 2 mo

Active ingredient

RASAGILINE MESYLATE

Strength

EQ 0.5MG BASE

Dosage form

TABLET

Route

ORAL

TE code

Application

NDA 021641

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7572834	Dec 05, 2026	in 6 mo	Product
7815942	Aug 27, 2027	in 1 yr 2 mo	SubstanceProductU-219